Abstract
Background and Purpose Plaque composition, but not stenosis degree, may play a key role in the development of recurrent ischemic events in patients with symptomatic, mild (<50%) carotid stenosis. This multi-center prospective cohort study was aimed to determine their clinical and radiological features and to evaluate the benefits of carotid endarterectomy (CEA) for them.
Methods This study included 124 patients with cerebrovascular or retinal ischemic events ipsilateral to mild carotid stenosis. Best medical therapy (BMT) was administered to all participants. CEA or carotid artery stenting (CAS) was implemented at each institution’s discretion. Baseline and 6-, 12-, and 24-month follow-up data were collected. Primary endpoint was ipsilateral ischemic stroke. Secondary endpoints included any stroke, ipsilateral TIA, ipsilateral ocular symptoms, any death, and plaque progression requiring CEA/CAS. Multivariate Cox proportional hazard model was used to evaluate the predictors for each endpoint.
Results Of 124 patients, 70 patients (56.5%) had the history of ipsilateral ischemic stroke and 51 (43.5%) had been treated with antiplatelet agents. Mean stenosis degree was 22.4±13.7%. Plaque composition was categorized into fibrous plaque in 22 patients, lipid-rich/necrotic core (LR/NC) in 25, and intraplaque hemorrhage (IPH) in 69. BMT was indicated for 59 patients, while CEA was performed in 63. The incidence of primary endpoint was significantly higher in BMT group than in CEA group (15.1% vs. 1.7%; HR, 0.18; 95%CI, 0.05–0.84; P=0.03). The predictors for ipsilateral ischemic stroke were CEA (HR, 0.18; 95%CI, 0.05–0.84; P=0.03) and IPH (HR, 1.92; 95%CI, 1.26–4.28; P=0.04). The results on secondary endpoints were very similar.
Conclusion IPH may highly predict subsequent cerebrovascular events, whereas CEA may reduce these risk during a 2-year follow-up in patients with symptomatic, mild carotid stenosis.
Registration This study has been registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) (UMIN000023635).
Contributors SK, KO, UM, and MS designed the study. DK wrote an original draft. All authors recruited patients. DK, KC, KY, KY, MM, SY, SM, KO, MU, MS, and SK analyzed the imaging data as the members of Central Judgement Committee and contributed to data analysis. SK takes final responsibility for the submitted publication.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) (registration number: UMIN000023635)
Funding Statement
No funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical Review Board, Toyama University Hospital (No. R2016042)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Non-standard Abbreviations and Acronyms
- BMT
- best medical therapy;
- CAS
- carotid artery stenting;
- CEA
- carotid endarterectomy;
- CI
- confidence interval;
- DWI
- diffusion-weighted imaging;
- ICC
- intraclass correlation coefficient;
- FLAIR
- fluid-attenuated inversion recovery;
- HR
- hazard ratio;
- IPH
- intraplaque hemorrhage;
- IQR
- interquartile range;
- LDL
- low-density lipoprotein;
- LR/NC
- lipid-rich or necrotic core;
- MRI
- magnetic resonance imaging;
- mRS
- modified Rankin Scale;
- NASCET
- North American Symptomatic Carotid Endarterectomy Trial;
- SD
- standard deviation;
- SIR
- signal intensity ratio;
- OR
- odds ratio;
- T1WI
- T1-weighted imaging;
- T2WI
- T2-weighted imaging;
- TIA
- transient ischemic attack;
- TOF
- time-of-flight